Lauren Sullivan NAFC Board Member
JOIN OUR NEWSLETTER
Receive custom tools to help you manage your condition and get the latest in bladder and bowel health from NAFC!
LAUREN SULLIVAN
Lauren Sullivan, an executive with more than 15 years of experience helping pharmaceutical and biotechnology clients develop and commercialize new therapies, has joined the Epstein Becker GreenHealth Care and Life Sciences practice.
Before joining EBG, Ms. Sullivan was Vice President of Healthcare Law at a biopharmaceutical company, where she co-led the company’s legal department. Prior to that, she was Vice President, Associate General Counsel, and Head of Alliance Management at a San Francisco biotech company, where she created and led its Healthcare and Business Law Group. Earlier in her career, Ms. Sullivan served as senior in-house legal counsel at various biopharmaceutical, pharmaceutical, and biotech companies. She began her legal career as an attorney in the Biotechnology & Life Science Practice Group of a national law firm.
“Lauren has vast in-house experience and understands the nuanced legal and operational challenges that bio-pharma companies face.” said Mark Lutes, Chair of the firm’s Board of Directors. “Lauren will marshal our FDA, clinical trial, compliance, and reimbursement resources and knowledge to address bio-pharma commercialization needs.”
“It is refreshing to see a law firm that looks at the bio-pharma industry through a dual legal and business lens and that understands that change in one area affects many others,” said Ms. Sullivan. “EBG has the full set of compliance, legal, and regulatory professionals who need to interact for successful product launch.”
“Lauren’s deep understanding of the full life cycle of products, from inception to market, will be particularly beneficial to our bio-pharma clients,” added George B. Breen, Chair of the firm’s National Health Care and Life Sciences Practice Steering Committee.
RELATED ARTICLES
The Financial Impact of Incontinence: Costs You May Not See
Incontinence is often discussed in terms of symptoms and quality of life but for many people, it also brings a steady (and sometimes surprising) financial burden. Beyond the obvious cost of pads, protective underwear, and skin-care products, there can be added expenses from laundry, missed work, caregiving needs, and medical visits. The good news: understanding where the costs come from is the first step toward reducing them—and getting the right treatment can be a cost-saver, not just a health improvement.
Speaking Up About Incontinence
For many people living with bladder leaks, the hardest part isn’t the symptoms themselves.
It’s deciding to talk about them.
Bladder leaks can feel too small to mention, too embarrassing to explain, or not “serious enough” to justify a doctor’s visit. Many people quietly manage symptoms for years—adjusting their routines, limiting activities, and hoping things don’t get worse.
If this sounds familiar, you’re not alone. And you’re not wrong for feeling this way.
Incontinence by the Numbers
How common it is, why it’s increasing, and what an aging population means for patients and families
Incontinence is often treated as something people should keep private — but the reality is that it’s extremely common, and it affects millions of Americans every day.
As our population ages, especially with Baby Boomers entering older adulthood, more people are living with bladder and bowel control problems. That means more patients seeking answers, more caregivers providing support, and greater impact on families and the healthcare system.
Understanding the numbers helps reduce stigma — and reminds people that they are not alone and help is available.
The Financial Impact of Incontinence: Costs You May Not See
Incontinence is often discussed in terms of symptoms and quality of life but for many people, it also brings a steady (and sometimes surprising) financial burden. Beyond the obvious cost of pads, protective underwear, and skin-care products, there can be added expenses from laundry, missed work, caregiving needs, and medical visits. The good news: understanding where the costs come from is the first step toward reducing them—and getting the right treatment can be a cost-saver, not just a health improvement.